Andrew Fisher, General Counsel at Verona Pharma plc (VRNA), sold 52,144 shares at $8.98 ($468K) on 2025-04-29, disclosed to the SEC on 2025-05-01.
Open-market sale of $468k VRNA by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.98 | 26,072 | $234K | 50.0% |
| 2 | $8.98 | 26,072 | $234K | 50.0% |
| Total | $8.98 avg | 52,144 | $468K | 100% |
| Filing → |
| VRNA | SELL | 2025-05-16 | $686K | — | Filing → |